by University of Utah Health Sciences In her Genomic Signal Processing Lab, Alter develops new mathematical methods that are uniquely suited for personalized medicine. Credit: Nathan L. Galli, University of Utah For the past 70 years, the best indicator of life expectancy for a patient with glioblastoma (GBM)—the most common and the most aggressive brain...
Surplus antioxidants are pathogenic for hearts and skeletal muscle
by Jeff Hansen, University of Alabama at Birmingham Many heart diseases are linked to oxidative stress, an overabundance of reactive oxygen species. The body reacts to reduce oxidative stress—where the redox teeter-totter has gone too far up—through production of endogenous antioxidants that reduce the reactive oxygen species. This balancing act is called redox homeostasis. But...
How the Lyme disease epidemic is spreading and why ticks are so hard to stop
by Jeff Hansen, University of Alabama at Birmingham Is personalized medicine cost-effective? University of Alabama at Birmingham researcher Nita Limdi, Pharm.D., Ph.D., and colleagues across the United States have answered that question for one medical treatment. Patients experiencing a heart attack—known as a myocardial infarction or an acute coronary syndrome—have sharply diminished blood flow in...
How the Lyme disease epidemic is spreading and why ticks are so hard to stop
by Durland Fish, The Conversation In the 1970s, an epidemic of mysterious arthritis-like symptoms began spreading among children in the lushly wooded area around Lyme, Connecticut. Scientists traced the cause to tick bites and named it Lyme disease, but why it had suddenly appeared there was a mystery. Similar symptoms had been documented on Long...
Pulmonary rehab associated with lower COPD mortality
(HealthDay)—Initiation of pulmonary rehabilitation within three months of hospital discharge for chronic obstructive pulmonary disease (COPD) is significantly associated with a lower risk for mortality at one year for Medicare beneficiaries, according to a study published in the May 12 issue of the Journal of the American Medical Association. Peter K. Lindenauer, M.D., from the...
Intelligent lung ultrasound provides crucial support for COVID-19 testing within minutes
by Hilde De Laat, Eindhoven University of Technology Establishing whether a patient is suffering from severe lung disease, possibly COVID-19, within a few minutes is possible using fairly simple ultrasound machines that are enhanced with artificial intelligence. A research team at Eindhoven University of Technology (TU/e) and the University of Trento in Italy has been...
Loss of taste or smell strongly predicts which health care workers will test positive for COVID-19
by Barbara Branning, University at Buffalo A study by a University at Buffalo investigator sheds new light on the link between early COVID-19 symptoms and eventual positive test results. The research could lead to new protocols for determining who will be tested and how best to use testing resources. One compelling finding of the study...
COVID-19 PUTS KIDS AT GREATER RISK THAN WE THOUGHT
Children, teens, and young adults have a greater risk for severe complications from COVID-19 than previously thought, a new study shows. The study, the first to describe the characteristics of seriously ill pediatric COVID-19 patients in North America, also shows kids with underlying health conditions have an even greater risk. “The idea that COVID-19 is...
AiRTouch Portable X-Ray Receives FDA Clearance, Can Be Used for COVID Diagnosis
The handheld device weighs in at 5.5 pounds (2.5 Kg) and resembles a large digital camera with a touchscreen. AiRTouch acquires images with the push of a button and can wirelessly transmit them to PACS (clinical image storage system), without the need for a computer. Its battery charges within two hours and can capture up...
New therapy more effective than cognitive behavioral therapy for depression
by Michael Addelman, University of Manchester A new therapy developed at The University of Manchester is better at treating depression than cognitive behavioral therapy—or CBT—seen as the gold standard by psychologists and health providers. The study, published in Frontiers in Psychology, is the first full-scale randomized trial of metacognitive therapy (MCT), developed by Professor Adrian...